Top compounds associated with response to POLR2I


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.11 0.0007
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.11 0.0008
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.11 0.0009
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.37 0.001
mRNA KIN001-055 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA KU-60019 CTRPv2 pan-cancer AAC 0.11 0.001
Download CSV